NCT06929442

Brief Summary

This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
36mo left

Started Feb 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Feb 2025Jun 2029

Study Start

First participant enrolled

February 10, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 16, 2025

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

3.8 years

First QC Date

April 4, 2025

Last Update Submit

May 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peters Delusions Inventory

    The Peters Delusions Inventory (PDI) is a brief 21-item survey using non-stigmatizing and non-clinical language that obtains ratings of common delusional experiences (e.g. paranoia, grandiosity, ideas of reference) and perceptual aberrations (e.g. experiences of being controlled; thought insertion, withdrawal, and echoing), i.e., psychotic experiences. The PDI also measures conviction, preoccupation, and distress related to these experiences. This scale is scored from 0-21, with higher scores indicating a greater number of experiences endorsed.

    Baseline, 4-weeks, 6 month, 12 months, and 24 months

Secondary Outcomes (37)

  • Beck Depression Inventory

    Baseline, 4-weeks, 6 month, 12 months, and 24 months

  • Spielberger State-Trait Anxiety Inventory

    Baseline, 4-weeks, 6 month, 12 months, and 24 months

  • Columbia-Suicide Severity Rating Scale

    Baseline, 4-weeks, 6 month, 12 months, and 24 months

  • UCLA Loneliness Scale

    Baseline, 4-weeks, 6 month, 12 months, and 24 months

  • Temporal Experience of Pleasure Scale

    Baseline, 4-weeks, 6 month, 12 months, and 24 months

  • +32 more secondary outcomes

Study Arms (2)

Resilience Training (RT)

EXPERIMENTAL

RT is a 4-week program of weekly 90-minute sessions in which participants are taught the following skills: mindfulness, self-compassion and mentalization.

Behavioral: Resilience Training (RT)

Life Skills Training (LST)

ACTIVE COMPARATOR

LST is a 4-week program of weekly 90-minute sessions, in which participants are provided information about helpful life skills, including financial literacy, health, physical and internet safety.

Behavioral: Life Skills Training (LST)

Interventions

RT is a 4-week program of weekly 90-minute sessions in which participants are taught the following skills: mindfulness, self-compassion and mentalization.

Resilience Training (RT)

LST is a 4-week program of weekly 90-minute sessions, in which participants are provided information about helpful life skills, including financial literacy, health, physical and internet safety.

Life Skills Training (LST)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Enrolled as a first or second year student (i.e., freshman or sophomore) in an undergraduate program at the college or university where the intervention takes place
  • Students who endorse some psychotic experiences (Peter's et al. Delusion Inventory (PDI) score \> 3)

You may not qualify if:

  • Inability to provide informed consent
  • Not proficient in English
  • Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization
  • Current enrollment in psychological or behavioral health treatment.
  • Current use of psychotropic medications (other than stimulants) prescribed by a physician.
  • A diagnosis of a serious, chronic mental illness as determined by the Mini-International Neuropsychiatric Interview (MINI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Charlestown, Massachusetts, 02129, United States

RECRUITING

MeSH Terms

Conditions

Psychotic DisordersMood DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Central Study Contacts

Daphne J Holt, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized trial with active control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 4, 2025

First Posted

April 16, 2025

Study Start

February 10, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

June 1, 2029

Last Updated

May 11, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

The investigators are sharing the data collected in this project via a two-tiered process via the NIMH Data Archive (http://nda.nih.gov/, NDA). The first tier is for the submission of descriptive/raw data while the study is ongoing. The second tier is for the submission of analyzed data at the time of the publication of results or when the study's primary aims have been achieved.

Shared Documents
CSR, ANALYTIC CODE
Time Frame
Study data will be come available once manuscripts are published.
Access Criteria
Data shared will be coded, with no PHI included.
More information

Locations